+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of fluid balance on the development of bronchopulmonary dysplasia in surfactant treated premature infants



Effect of fluid balance on the development of bronchopulmonary dysplasia in surfactant treated premature infants



Pediatric Research 23(4 Part 2): 507A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028167411

Download citation: RISBibTeXText


Related references

Timing of Surfactant Treatment in Extremely Premature Infants - Effects on Mortality and Development of Bronchopulmonary Dysplasia (Bpd). Pediatric Research 68: 262-263, 2010

Prophylactic indomethacin Effect on pulmonary hemorrhage and bronchopulmonary dysplasia in surfactant-treated infants less than 1250 grams. Pediatric Research 39(4 Part 2): 203A, 1996

Effect of surfactant on radiographic and clinical course of infants with respiratory distress syndrome rds and development of bronchopulmonary dysplasia bpd. American Review of Respiratory Disease 139(4 Part 2): A565, 1989

Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 120(6): 1260-1269, 2007

Incidence of bronchopulmonary dysplasia in premature infants with respiratory distress syndrome not receiving exogenous surfactant treatment. Pediatric Research 35(4 Part 2): 285A, 1994

A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 98(2 Pt 1): 204-210, 1996

Prognosis factors in severe bronchopulmonary dysplasia. A retrospective study of 65 premature infants with bronchopulmonary dysplasia. Archives Francaises de Pediatrie 44(6): 423-431, 1987

Myocardial hypertrophy in four premature infants with bronchopulmonary dysplasia treated with glucocorticoids. Archives de Pediatrie 2(Suppl. 1): 128S, 1995

Growth and development in premature infants with bronchopulmonary dysplasia (BPD). 2007

Later growth and development in premature infants with bronchopulmonary dysplasia (BPD). Journal of Pediatric & Perinatal Nutrition 2(1): 67-77, 1988

Early identification of those at risk of moderate to severe bronchopulmonary dysplasia m sbpd in surfactant treated infants. Pediatric Research 25(4 Part 2): 229A, 1989

Lung parenchymal development in premature infants without bronchopulmonary dysplasia. Pediatric Pulmonology 50(12): 1313-1319, 2016

The development of the circadian rhythm in premature infants with bronchopulmonary dysplasia in the NICU. Journal of Investigative Medicine 44(7): 367A, 1996

Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. American Journal of Physiology. Lung Cellular and Molecular Physiology 283(5): L1086-L1093, 2002

Ability to identify surfactant-treated newborn infants at risk for developing significant bronchopulmonary dysplasia by eight hours of life. Pediatric Research 35(4 Part 2): 252A, 1994